We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
-5.02%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$593M
AUM Growth
-$12M
(-2%)
Cap. Flow
+$24.6M
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
49.61%
Holding
3,046
New
350
Increased
1,337
Reduced
784
Closed
167
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RPAR Risk Parity ETF
RPAR
|
+$5.24M |
| 2 |
Golub Capital BDC
GBDC
|
+$3.49M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$3.1M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$2.79M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$1.03M |
| 2 |
Nike
NKE
|
+$772K |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$728K |
| 4 |
Kinder Morgan
KMI
|
+$708K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$594K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.66% |
| 2 | Technology | 11.68% |
| 3 | Healthcare | 5.39% |
| 4 | Consumer Discretionary | 4.17% |
| 5 | Energy | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Boston Scientific
BSX
$71.5B
| $465K | 0.08% |
11,999
+321
| +3% | +$12.9K |
|
|
NVO
152
Novo Nordisk
NVO
$209B
| $465K | 0.08% |
9,344
+56
| +0.6% | +$3K |
|
|
ETRN
153
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $464K | 0.08% |
61,991
-5,293
| -8% | -$44.3K |
|
154
Thermo Fisher Scientific
TMO
$220B
| $462K | 0.08% |
911
+106
| +13% | +$59.3K |
|
155
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $457K | 0.08% |
3,750
-9
| -0.2% | -$1.22K |
|
156
DT Midstream
DTM
$13.4B
| $456K | 0.08% |
8,786
-1,144
| -12% | -$61.7K |
|
157
Vanguard Dividend Appreciation ETF
VIG
$114B
| $456K | 0.08% |
3,376
| – | – |
|
158
American Tower
AMT
$80.4B
| $454K | 0.08% |
2,114
+17
| +0.8% | +$4.37K |
|
159
Roper Technologies
ROP
$39.8B
| $450K | 0.08% |
1,250
-12
| -1% | -$4.88K |
|
160
Vanguard ESG US Stock ETF
ESGV
$13.6B
| $446K | 0.08% |
7,087
+5,107
| +258% | +$358K |
|
161
PayPal
PYPL
$50.5B
| $446K | 0.08% |
5,185
+351
| +7% | +$31.1K |
|
162
Applied Materials
AMAT
$428B
| $442K | 0.07% |
5,394
+1,014
| +23% | +$97.8K |
|
163
Novartis
NVS
$297B
| $437K | 0.07% |
5,753
+56
| +1% | +$4.64K |
|
164
Cincinnati Financial
CINF
$27.1B
| $434K | 0.07% |
4,840
+359
| +8% | +$37K |
|
165
Amgen
AMGN
$222B
| $431K | 0.07% |
1,911
+962
| +101% | +$233K |
|
166
Netflix
NFLX
$309B
| $424K | 0.07% |
17,990
-1,750
| -9% | -$38.9K |
|
167
Hershey
HSY
$36.6B
| $423K | 0.07% |
1,919
+66
| +4% | +$14.8K |
|
168
Qualcomm
QCOM
$176B
| $422K | 0.07% |
3,731
-231
| -6% | -$31.7K |
|
|
HZNP
169
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $417K | 0.07% |
6,743
-58
| -0.9% | -$4.05K |
|
170
KLA
KLAC
$259B
| $413K | 0.07% |
13,650
-40
| -0.3% | -$1.39K |
|
171
State Street Technology Select Sector SPDR ETF
XLK
$124B
| $413K | 0.07% |
6,960
-642
| -8% | -$43.8K |
|
172
Berkshire Hathaway Class A
BRK.A
$1.12T
| $406K | 0.07% |
+1
| New | +$428K |
|
|
FISV
173
Fiserv Inc
FISV
$27.9B
| $406K | 0.07% |
4,336
+165
| +4% | +$16.8K |
|
174
Illinois Tool Works
ITW
$84.5B
| $400K | 0.07% |
2,212
+135
| +6% | +$26.6K |
|
175
MetLife
MET
$62.1B
| $388K | 0.07% |
6,391
-865
| -12% | -$55.3K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Lindbrook Capital held 3,046 positions worth $593M, down 2% from $605M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Lindbrook Capital deployed $24.6M of net new capital in Q3 2022, opening 350 new positions and adding to 1,337 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1 share worth $406K.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $1.03M trimmed.
- Lindbrook Capital's largest Q3 2022 buy was Berkshire Hathaway Class A: 1 share worth $406K.
- Lindbrook Capital added most to RPAR Risk Parity ETF in Q3 2022, an estimated $5.24M increase.
- Lindbrook Capital's biggest Q3 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.03M.
- Lindbrook Capital fully exited ProShares UltraShort S&P500 in Q3 2022, selling an estimated $219K.
- Lindbrook Capital's ten largest holdings make up 50% of its $593M portfolio in Q3 2022.
- Lindbrook Capital opened 350 new positions and closed 167 in Q3 2022.
- Lindbrook Capital's portfolio value fell 2% quarter-over-quarter to $593M.
Based on Lindbrook Capital's 13F filing for Q3 2022, filed 10 Nov 2022.